Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of Erythropoietin (EPO) Drugs market.

Scope of the Report:

According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years.

The global Erythropoietin (EPO) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Erythropoietin (EPO).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Erythropoietin (EPO) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Erythropoietin (EPO) market by product type and applications/end industries.

Market Segment by Companies, this report covers

Johnson & Johnson

Celltrion

Teva Pharmaceutical

Amgen

F. Hoffman-La Roche

LG Life Sciences

Biocon

Intas Pharmaceuticals

Sun Pharmaceutical

Dr. Reddy's Laboratories

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Biologics

Biosimilars

Market Segment by Applications, can be divided into

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Online Sales

Table of Contents

1 Erythropoietin (EPO) Market Overview

1.1 Product Overview and Scope of Erythropoietin (EPO)

1.2 Classification of Erythropoietin (EPO) by Types

1.2.1 Global Erythropoietin (EPO) Revenue Comparison by Types (2017-2023)

1.2.2 Global Erythropoietin (EPO) Revenue Market Share by Types in 2017

1.2.3 Biologics

1.2.4 Biosimilars

1.3 Global Erythropoietin (EPO) Market by Application

1.3.1 Global Erythropoietin (EPO) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Drug Stores

1.3.5 Online Sales

1.4 Global Erythropoietin (EPO) Market by Regions

1.4.1 Global Erythropoietin (EPO) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Erythropoietin (EPO) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Erythropoietin (EPO) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Erythropoietin (EPO) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Erythropoietin (EPO) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Erythropoietin (EPO) Status and Prospect (2013-2023)

1.5 Global Market Size of Erythropoietin (EPO) (2013-2023)

2 Manufacturers Profiles

2.1 Johnson & Johnson

2.1.1 Business Overview

2.1.2 Erythropoietin (EPO) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Johnson & Johnson Erythropoietin (EPO) Revenue, Gross Margin and Market Share (2016-2017)

2.2 Celltrion

2.2.1 Business Overview

2.2.2 Erythropoietin (EPO) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Celltrion Erythropoietin (EPO) Revenue, Gross Margin and Market Share (2016-2017)

2.3 Teva Pharmaceutical

2.3.1 Business Overview

2.3.2 Erythropoietin (EPO) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Teva Pharmaceutical Erythropoietin (EPO) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Amgen

2.4.1 Business Overview

2.4.2 Erythropoietin (EPO) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Amgen Erythropoietin (EPO) Revenue, Gross Margin and Market Share (2016-2017)

2.5 F. Hoffman-La Roche

2.5.1 Business Overview

2.5.2 Erythropoietin (EPO) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 F. Hoffman-La Roche Erythropoietin (EPO) Revenue, Gross Margin and Market Share (2016-2017)

2.6 LG Life Sciences

2.6.1 Business Overview

2.6.2 Erythropoietin (EPO) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 LG Life Sciences Erythropoietin (EPO) Revenue, Gross Margin and Market Share (2016-2017)

2.7 Biocon

2.7.1 Business Overview

2.7.2 Erythropoietin (EPO) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Biocon Erythropoietin (EPO) Revenue, Gross Margin and Market Share (2016-2017)

2.8 Intas Pharmaceuticals

2.8.1 Business Overview

2.8.2 Erythropoietin (EPO) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Intas Pharmaceuticals Erythropoietin (EPO) Revenue, Gross Margin and Market Share (2016-2017)

2.9 Sun Pharmaceutical

2.9.1 Business Overview

2.9.2 Erythropoietin (EPO) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Sun Pharmaceutical Erythropoietin (EPO) Revenue, Gross Margin and Market Share (2016-2017)

2.10 Dr. Reddy's Laboratories

2.10.1 Business Overview

2.10.2 Erythropoietin (EPO) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Dr. Reddy's Laboratories Erythropoietin (EPO) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Erythropoietin (EPO) Market Competition, by Players

3.1 Global Erythropoietin (EPO) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Erythropoietin (EPO) Players Market Share

3.2.2 Top 10 Erythropoietin (EPO) Players Market Share

3.3 Market Competition Trend

4 Global Erythropoietin (EPO) Market Size by Regions

4.1 Global Erythropoietin (EPO) Revenue and Market Share by Regions

4.2 North America Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

4.3 Europe Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

4.5 South America Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

5 North America Erythropoietin (EPO) Revenue by Countries

5.1 North America Erythropoietin (EPO) Revenue by Countries (2013-2018)

5.2 USA Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

5.3 Canada Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

5.4 Mexico Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

6 Europe Erythropoietin (EPO) Revenue by Countries

6.1 Europe Erythropoietin (EPO) Revenue by Countries (2013-2018)

6.2 Germany Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

6.3 UK Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

6.4 France Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

6.5 Russia Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

6.6 Italy Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Erythropoietin (EPO) Revenue by Countries

7.1 Asia-Pacific Erythropoietin (EPO) Revenue by Countries (2013-2018)

7.2 China Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

7.3 Japan Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

7.4 Korea Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

7.5 India Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

8 South America Erythropoietin (EPO) Revenue by Countries

8.1 South America Erythropoietin (EPO) Revenue by Countries (2013-2018)

8.2 Brazil Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

8.3 Argentina Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

8.4 Colombia Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Erythropoietin (EPO) by Countries

9.1 Middle East and Africa Erythropoietin (EPO) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

9.3 UAE Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

9.4 Egypt Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

9.6 South Africa Erythropoietin (EPO) Revenue and Growth Rate (2013-2018)

10 Global Erythropoietin (EPO) Market Segment by Type

10.1 Global Erythropoietin (EPO) Revenue and Market Share by Type (2013-2018)

10.2 Global Erythropoietin (EPO) Market Forecast by Type (2018-2023)

10.3 Biologics Revenue Growth Rate (2013-2023)

10.4 Biosimilars Revenue Growth Rate (2013-2023)

11 Global Erythropoietin (EPO) Market Segment by Application

11.1 Global Erythropoietin (EPO) Revenue Market Share by Application (2013-2018)

11.2 Erythropoietin (EPO) Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacies Revenue Growth (2013-2018)

11.4 Retail Pharmacies Revenue Growth (2013-2018)

11.5 Drug Stores Revenue Growth (2013-2018)

11.6 Online Sales Revenue Growth (2013-2018)

12 Global Erythropoietin (EPO) Market Size Forecast (2018-2023)

12.1 Global Erythropoietin (EPO) Market Size Forecast (2018-2023)

12.2 Global Erythropoietin (EPO) Market Forecast by Regions (2018-2023)

12.3 North America Erythropoietin (EPO) Revenue Market Forecast (2018-2023)

12.4 Europe Erythropoietin (EPO) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Erythropoietin (EPO) Revenue Market Forecast (2018-2023)

12.6 South America Erythropoietin (EPO) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Erythropoietin (EPO) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Erythropoietin (EPO) Picture

Table Product Specifications of Erythropoietin (EPO)

Table Global Erythropoietin (EPO) and Revenue (Million USD) Market Split by Product